Dai MS - Search Results

1

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.

Dai MS, Chao TY, Kao WY, Shyu RY, Liu TM. Dai MS, et al. Ann Hematol. 2004 Dec;83(12):769-74. doi: 10.1007/s00277-004-0899-y. Epub 2004 Aug 25. Ann Hematol. 2004. PMID: 15338194

2

Calcification in splenic lymphoma before chemotherapy.

Dai MS, Chao TY, Yu CY. Dai MS, et al. South Med J. 2003 Aug;96(8):836-7. doi: 10.1097/01.SMJ.0000083855.35636.EA. South Med J. 2003. PMID: 14515933 No abstract available.

3

Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy.

Dai MS, Hsieh AT, Chao TY. Dai MS, et al. Support Care Cancer. 2004 Jul;12(7):537-9. doi: 10.1007/s00520-004-0631-4. Epub 2004 Apr 28. Support Care Cancer. 2004. PMID: 15114479

4

Non-Hodgkin's lymphoma of the stomach: treatment outcomes for 57 patients over a 20-year period.

Ho CL, Hsieh AT, Dai MS, Chen YC, Kao WY, Chao TY. Ho CL, et al. Among authors: dai ms. J Chin Med Assoc. 2005 Jan;68(1):11-5. doi: 10.1016/S1726-4901(09)70125-X. J Chin Med Assoc. 2005. PMID: 15742857 Free article.

5

Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?

Dai MS, Chao TY. Dai MS, et al. Breast Cancer Res Treat. 2005 Jul;92(1):95-6. doi: 10.1007/s10549-005-1942-y. Breast Cancer Res Treat. 2005. PMID: 15980997 No abstract available.

6

Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumors.

Dai MS, Nitcheu-Tefit J, Alcock S, Ramirez-Jimenez F, Chao TY, Baril P, Rocha M, Brett SJ, Stauss HJ, Vassaux G. Dai MS, et al. J Immunother. 2009 Oct;32(8):845-55. doi: 10.1097/CJI.0b013e3181aee259. J Immunother. 2009. PMID: 19752749

7

Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine.

Tsai SH, Dai MS, Yu JC, Ho CL, Chen YC, Wu YY, Chang PY, Kao WY, Chao TY. Tsai SH, et al. Among authors: dai ms. Support Care Cancer. 2011 Nov;19(11):1779-87. doi: 10.1007/s00520-010-1019-2. Epub 2010 Oct 7. Support Care Cancer. 2011. PMID: 20927554 Clinical Trial.

8

Improved outcomes in buccal squamous cell carcinoma.

Lin CS, Jen YM, Kao WY, Ho CL, Dai MS, Shih CL, Cheng JC, Chang PY, Huang WY, Su YF. Lin CS, et al. Among authors: dai ms. Head Neck. 2013 Jan;35(1):65-71. doi: 10.1002/hed.22916. Epub 2012 Jan 20. Head Neck. 2013. PMID: 22266920

9

Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer.

Dai MS, Vassaux G, Xu M, You RI, Hsieh YF, Ouisse LH, Lo KY, Sytwu HK, Chao TY. Dai MS, et al. Vaccine. 2012 Nov 6;30(48):6903-11. doi: 10.1016/j.vaccine.2012.09.001. Epub 2012 Sep 14. Vaccine. 2012. PMID: 22982404

10

Malignant bowel obstruction: A retrospective clinical analysis.

Chen JH, Huang TC, Chang PY, Dai MS, Ho CL, Chen YC, Chao TY, Kao WY. Chen JH, et al. Among authors: dai ms. Mol Clin Oncol. 2014 Jan;2(1):13-18. doi: 10.3892/mco.2013.216. Epub 2013 Nov 19. Mol Clin Oncol. 2014. PMID: 24649301 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page